| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
24-28 |
G_3 |
denotes |
ACE2 |
| T2 |
24-28 |
PG_10 |
denotes |
ACE2 |
| T3 |
24-28 |
PR:000003622 |
denotes |
ACE2 |
| T4 |
61-69 |
SP_7 |
denotes |
COVID-19 |
| T5 |
99-130 |
PG_10 |
denotes |
angiotensin-converting enzyme 2 |
| T6 |
99-130 |
PR:000003622 |
denotes |
angiotensin-converting enzyme 2 |
| T7 |
132-136 |
G_3 |
denotes |
ACE2 |
| T8 |
132-136 |
PG_10 |
denotes |
ACE2 |
| T9 |
132-136 |
PR:000003622 |
denotes |
ACE2 |
| T10 |
163-169 |
SO:0000417 |
denotes |
domain |
| T11 |
202-249 |
SP_7 |
denotes |
severe acute respiratory syndrome coronavirus 2 |
| T12 |
215-226 |
UBERON:0001004 |
denotes |
respiratory |
| T13 |
215-226 |
GO:0045333 |
denotes |
respiratory |
| T14 |
251-261 |
SP_7 |
denotes |
SARS-CoV-2 |
| T15 |
287-292 |
NCBITaxon:10239 |
denotes |
virus |
| T16 |
287-303 |
GO:0035376 |
denotes |
virus entry into |
| T17 |
338-342 |
G_3 |
denotes |
ACE2 |
| T18 |
338-342 |
PG_10 |
denotes |
ACE2 |
| T19 |
338-342 |
PR:000003622 |
denotes |
ACE2 |
| T20 |
381-391 |
SP_7 |
denotes |
SARS-CoV-2 |
| T21 |
449-453 |
G_3 |
denotes |
ACE2 |
| T22 |
449-453 |
PG_10 |
denotes |
ACE2 |
| T23 |
449-453 |
PR:000003622 |
denotes |
ACE2 |
| T24 |
574-578 |
G_3 |
denotes |
ACE2 |
| T25 |
574-578 |
PG_10 |
denotes |
ACE2 |
| T26 |
574-578 |
PR:000003622 |
denotes |
ACE2 |
| T27 |
671-675 |
G_3 |
denotes |
ACE2 |
| T28 |
671-675 |
PG_10 |
denotes |
ACE2 |
| T29 |
671-675 |
PR:000003622 |
denotes |
ACE2 |
| T30 |
813-817 |
G_3 |
denotes |
ACE2 |
| T31 |
813-817 |
PG_10 |
denotes |
ACE2 |
| T32 |
813-817 |
PR:000003622 |
denotes |
ACE2 |
| T33 |
1004-1018 |
DG_37 |
denotes |
angiotensin-II |
| T34 |
1004-1018 |
PR:000036009 |
denotes |
angiotensin-II |
| T35 |
1028-1039 |
SO:0100019 |
denotes |
active site |
| T36 |
1043-1047 |
PR:000003622 |
denotes |
ACE2 |
| T37 |
1043-1047 |
G_3 |
denotes |
ACE2 |
| T38 |
1043-1047 |
PG_10 |
denotes |
ACE2 |
| T39 |
1383-1387 |
G_3 |
denotes |
ACE2 |
| T40 |
1383-1387 |
PG_10 |
denotes |
ACE2 |
| T41 |
1383-1387 |
PR:000003622 |
denotes |
ACE2 |
| T42 |
1414-1418 |
G_3 |
denotes |
ACE2 |
| T43 |
1414-1418 |
PG_10 |
denotes |
ACE2 |
| T44 |
1414-1418 |
PR:000003622 |
denotes |
ACE2 |
| T45 |
1498-1516 |
PG_18 |
denotes |
Spike glycoprotein |
| T46 |
1498-1516 |
PG_1 |
denotes |
Spike glycoprotein |
| T47 |
1504-1516 |
CHEBI:17089 |
denotes |
glycoprotein |
| T48 |
1504-1516 |
BV_11 |
denotes |
glycoprotein |
| T49 |
1504-1516 |
CHEBI:17089 |
denotes |
glycoprotein |
| T50 |
1524-1534 |
SP_7 |
denotes |
SARS-CoV-2 |
| T51 |
1574-1585 |
GO:0009056 |
denotes |
degradation |
| T52 |
1657-1661 |
G_3 |
denotes |
ACE2 |
| T53 |
1657-1661 |
PG_10 |
denotes |
ACE2 |
| T54 |
1657-1661 |
PR:000003622 |
denotes |
ACE2 |
| T55 |
1718-1726 |
SP_7 |
denotes |
COVID-19 |
